Carson Advisory Inc.

SEC CIK: 0001909304
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

NGM holding history

NGM Biopharmaceuticals Inc in every 13F filed by Carson Advisory Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NGM overview All 13F holders of NGM Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2023

Holdings of NGM by Carson Advisory Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−22,550−100.0%	Sold out	Holders
Q1 2024	22,550	$35.9K	<0.1%	00.0%	Unchanged	Holders
Q4 2023	22,550	$19.4K	<0.1%	+6,700+42.3%	Added	Holders
Q3 2023	15,850	$17.0K	<0.1%	+15,850	New	Holders